PlainPharmaWatch

CMS Open Payments · Tool

Merz North America, Inc. vs Ortho Development Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Ortho Development Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 918, versus 306 for the other company. Its single largest recorded recipient represents 16.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Merz North America, Inc.
HHI 306 · top recipient 12.8%
Ranked #1,455 of 1,838 companies by HHI
Ortho Development Corporation
HHI 918 · top recipient 16.1%
Ranked #1,061 of 1,838 companies by HHI

Payment Overview

Total Payments
$3.6M
% of Industry
0.0%
Transactions
14,835
Avg per Transaction
$245.39
Recipients
14,831
Avg per Recipient
$245.45
Payment Types
4
Top Payment Type
Consulting Fee
Total Payments
$3.6M
% of Industry
0.0%
Transactions
924
Avg per Transaction
$3.9K
Recipients
924
Avg per Recipient
$3.9K
Payment Types
5
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Merz North America, Inc. vs Ortho Development Corporation - total reported payments in CMS Open Payments PY2024

Merz North America, Inc.$3.6MOrtho Development Corporati…$3.6M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Merz North America, Inc.

Consulting Fee $2.0M

57.6%

Food and Beverage $893.8K

25.5%

Travel and Lodging $585.7K

16.7%

Education $3.2K

0.1%

Ortho Development Corporation

Royalty or License $3.2M

90.4%

Consulting Fee $246.9K

6.9%

Travel and Lodging $68.5K

1.9%

Food and Beverage $27.2K

0.8%

Entertainment $337.64

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Merz North America, Inc.

  1. 1

    ROSS RADUSKY

    $448,755.24 · 15 txns

  2. 2

    SABRINA GUILLEN FABI

    $354,200.08 · 38 txns

  3. 3

    JEREMY B GREEN

    $67,344.42 · 28 txns

  4. 4

    JENNIFER LEVINE

    $65,199.16 · 46 txns

  5. 5

    GIDEON PUI YUEN KWOK

    $62,284.56 · 26 txns

Ortho Development Corporation

  1. 1

    THOMAS CALTON

    $576,324.63 · 26 txns

  2. 2

    NATHAN MOMBERGER

    $530,701.58 · 13 txns

  3. 3

    JOSHUA HICKMAN

    $420,400.86 · 46 txns

  4. 4

    FRIEDRICH BOETTNER

    $419,703.47 · 30 txns

  5. 5

    MANISH PATEL

    $301,450.87 · 56 txns

Summary Comparison

Metric Merz North America, Inc. Ortho Development Corporation
Total Payments $3.6M $3.6M
% of Industry Total 0.0% 0.0%
Transaction Count 14,835 924
Avg per Transaction $245.39 $3.9K
Recipient Count 14,831 924
Avg per Recipient $245.45 $3.9K
Payment Type Count 4 5
Top Payment Type Consulting Fee Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.